Is ATYR or BCDA more undervalued in 2026?

CirclFi compares aTyr Pharma, Inc. (ATYR) and BioCardia, Inc. (BCDA) using 13 institutional-grade valuation models. ATYR has a Quality of Company score of 4.9/10 while BCDA scores 4.4/10.

Which is a better buy — ATYR or BCDA?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ATYR and BCDA valuations compare?

ATYR at $0.54 and BCDA at $0.93 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ATYR vs BCDA Valuation Comparison 2026 — Intrinsic Value Analysis

ATYR

Biological Products, (No Diagnostic Substances)

aTyr Pharma, Inc.

Quality

4.9

out of 10

Value Trap

WARN

Price

$0.54

Last close

Models

9/13

Active

BCDA

Biological Products, (No Diagnostic Substances)

BioCardia, Inc.

Quality

4.4

out of 10

Value Trap

WARN

Price

$0.93

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	ATYR Fair Value	ATYR Upside	BCDA Fair Value	BCDA Upside
Bayesian DCF	Intrinsic	$0.15	-72.4%	$0.28	-70.0%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.72	+32.9%	$0.02	-98.0%
Dynamic NAV	Asset-Based	$1.29	+137.8%	$1.52	+63.6%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ATYR vs BCDA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ATYR vs BCDA — Which Stock Is More Undervalued?

ATYR scores higher with a 4.9/10 quality rating vs BCDA's 4.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing aTyr Pharma, Inc. (ATYR) and BioCardia, Inc. (BCDA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ATYR currently trades at $0.54 with a QOC of 4.9/10, while BCDA trades at $0.93 with a QOC of 4.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).